All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML
The AML Hub will hold a virtual satellite symposium at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), on August 30, 2020, at 8:30 A.M. (CEST), in Auditorium 1. Gert Ossenkoppele, Amsterdam University Medical Center, Amsterdam, NL, explains why you should join the virtual AML Hub Satellite Symposium.
Gert Ossenkoppele explains why you should join the virtual AML Hub Satellite Symposium
During the AML Hub Satellite Symposium, five international experts, Gert Ossenkoppele, Jacqueline Cloos, Christian Thiede, Adriano Venditti, and Charles Craddock will discuss the latest developments in measurable residual disease (MRD) assessment: How does MRD impact outcome of stem cell transplantation in AML, now and in the future?
EHA 2019 | What is the clinical value of new drugs in AML?
Gert Ossenkoppele from the UMC Amsterdam, Netherlands (NL), talks about the clinical value of new drugs in acute myeloid leukemia (AML).
Highlights of the AML Hub Satellite Symposium
In this video, Gert Ossenkoppele, Amsterdam University Medical Center, Amsterdam, NL, discusses his highlights from the AML Hub Satellite Symposium.
Subscribe to get the best content related to AML delivered to your inbox